ADC Therapeutics Reports Narrower Q1 2026 Loss, Beats Estimates

[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence Related Coverage Deep Dive ADC Therapeutics Q1 2026: $0.13/share Loss Beats Estimates — Deep Dive May 4, 2026 Breaking News ADC Therapeutics Releases Q1 2026 Financial Results May 4, 2026 ADCT|Adj. Loss Per…



